Recent Updates
Recently added Catalysts
FULC Positive Sentiment

Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET

Tuesday, February 18, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Fulcrum Therapeutics, Inc. has scheduled the release of its fourth quarter and full year 2024 financial results on February 25, 2025. Prior to the U.S. financial markets opening, management will host a conference call and webcast at 8:00 a.m. ET to discuss these results. Participants can register for the call and will receive unique access details. An archived replay of the webcast will also be made available following the live event.
Price reaction · baseline $3.69 (2025-02-14 close) · hit after-hours · clean, no other FULC news in the window
day 0 close · peak
+2.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of Q4 and full year 2024 financial results demonstrates transparency.
  • The company's focus on genetically defined rare diseases highlights its niche expertise.
  • The provision of a conference call allows for engagement with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
15.6%
average across 6 past catalysts
Cash runway
~59 mo
Minimal dilution risk
Lead asset
Pociredir
Phase 2 · Sickle Cell Disease

Full Press Release Details

CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its fourth quarter and full year 2024 financial results will be released on Tuesday, February 25, 2025, before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.
Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s website at www.fulcrumtx.com or by clicking here. Following the live webcast, an archived replay will also be available.
About Fulcrum Therapeutics

Frequently Asked Questions

When will Fulcrum Therapeutics release its 2024 financial results?

Fulcrum Therapeutics will release its 2024 financial results on February 25, 2025.

What time is the conference call for Fulcrum Therapeutics' results?

The conference call is scheduled for 8:00 a.m. ET on February 25, 2025.

How can I access the Fulcrum Therapeutics conference call?

Register via the provided link to receive dial-in details for the call.

Is there a webcast available for the financial results discussion?

Yes, an audio webcast will be available on Fulcrum's Investor Relations website.

Will there be a recording of the conference call?

Yes, an archived replay of the webcast will be available after the live event.

ShareAdd on Google
Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics financial results conference call rare diseases
Last updated: Feb 18, 2025

Biotech snapshot

Cash runway
$319M liquidity · $5M/mo burn
~59 mo
Minimal dilution risk
Lead asset
PociredirPhase 2
Sickle Cell Disease →

Catalyst track record

+32%
best trade around FULC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for FULC.

See every catalyst's timing & PoA →